Aspochalasins I, J, and K: Three New Cytotoxic Cytochalasans of Aspergillus flavipes from the Rhizosphere of Ericameria laricifolia of the Sonoran Desert

Journal of Natural Products

Volumn 67, Issue 3, 2004, Pages 328-332

  Zhou, Guang Xiong ^a   Wijeratne, E M Kithsiri ^a   Bigelow, Donna ^a   Pierson III, Leland S ^a   VanEtten, Hans D ^a   Gunatilaka, A A Leslie ^a  

^a Environmental Research Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPOCHALASIN C; ASPOCHALASIN D; ASPOCHALASIN E; ASPOCHALASIN I; ASPOCHALASIN J; ASPOCHALASIN K; CYTOCHALASAN; CYTOTOXIC AGENT; PACLITAXEL; TMC 169; UNCLASSIFIED DRUG;

ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVIPES; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; ERICAMERIA LARICIFOLIA; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE SEQUENCE; RHIZOSPHERE; STRUCTURE ANALYSIS;

ANTINEOPLASTIC AGENTS; ARIZONA; ASPERGILLUS; ASTERACEAE; CYTOCHALASINS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOLECULAR STRUCTURE; TUMOR CELLS, CULTURED;

ASPERGILLUS; ASPERGILLUS FLAVIPES; ERICAMERIA; ERICAMERIA LARICIFOLIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 1642547014     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np030353m     Document Type: Article

References (14)

1. Studies on Arid Land Plants and Microorganisms, Part 2. For Part 1, see: Wijeratne, E. M. K.; Turbyville, T. J.; Bigelow, D.; Zhang, Z.; Pierson, L. S., III; VanEtten, H. D.; Whitesell, L.; Canfield, L. M.; Gunatilaka, A. A. L. J. Nat. Prod. 2003, 66, 1567-1573.
2. (a) Natori, S.; Yahara, I. In Mycotoxins and Phytoalexins; Sharma, R. P., Salunkhe, D. K., Eds.; CRC Press: Boca Raton, Fl, 1991; pp 291-336.
3. (b) Dagne, E.; Gunatilaka, A. A. L.; Asmellash, S.; Abate, D.; Kingston, D. G. I.; Hofmann, G. A.; Johnson, R. K. Tetrahedron 1994, 50, 5615-5620.
4. (a) Keller-Schierlein, W.; Kupfer, E. Helv. Chim. Acta 1979, 62, 1501-1523.
5. (b) Neupert-Laves, K.; Dobler, M. Helv. Chim. Acta 1982, 65, 1426-1431.
6. (a) Tomikawa, T.; Shin-Ya, K.; Kinoshita, T.; Miyajima, A.; Seto, H.; Hayakawa, Y. J. Antibiot. 2001, 54, 379-381.
7. (b) Tomikawa, T.; Shin-Ya, K.; Seto, H.; Okusa, N.; Kajiura, T.; Hayakawa, Y. J. Antibiot. 2002, 55, 666-668.
8. Naruse, M.; Yamamoto, H.; Murata, S.; Sawada, Y.; Fukagawa, Y.; Oki, T. J. Antibiot. 1993, 46, 679-681.
9. Fang, F.; Ui, H.; Shiomi, K.; Masuma, R.; Yamaguchi, Y.; Zhang, C. G.; Zhang, X. W.; Tanaka, Y.; Omura, S. J. Antibiot. 1997, 50, 919-925.
10. Kohno J.; Nonaka, N.; Nishio, M.; Ohnuki T.; Kawano, K.; Okuda, T.; Komatsubara, S. J. Antibiot. 1999, 52, 575-577.
11. Alvi, K. A.; Nair, B.; Pu, H.; Ursino, R.; Gallo, C.; Mocek, V. J. Org. Chem. 1997, 62, 2148-2151.
12. Stournaras, C.; Stiakaki, E.; Koukouritaki S. B.; Theodoropoules, P. A.; Kalmanti, M.; Fostinis, Y.; Gravanis, A. Biochem. Phamacol. 1996, 52, 1339-1346.
13. Willker, W.; Leibfritz, D.; Kerssebaum, R.; Bermel, W. Magn. Reson. Chem. 1993, 31, 287-292.
14. Rubinstein, L. V.; Shoemaker, R. H.; Paul, K. D.; Simon, R. M.; Tosini, S.; Skehan, P.; Sudiero, D. A.; Monks, A.; Boyd, M. R. J. Nat. Cancer Inst. 1990, 82, 1113-1118.